102
Views
1
CrossRef citations to date
0
Altmetric
Lens

Observation of Cyclosporin A: Sustained Release Intraocular Lens Implantation in Rabbit Eyes

, , , &
Pages 1508-1515 | Received 08 Mar 2022, Accepted 28 Jul 2022, Published online: 22 Aug 2022

References

  • Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology. 1998;105(7):1213–1221. doi:10.1016/S0161-6420(98)97023-3.
  • Findl O, Drexler W, Menapace R, Georgopoulos M, Rainer G, Hitzenberger CK, Fercher AF. Changes in intraocular lens position after neodymium:YAG capsulotomy. J Cataract Refract Surg. 1999;25(5):659–662. doi:10.1016/S0886-3350(99)00010-3.
  • Awasthi N, Guo S, Wagner BJ. Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol. 2009;127(4):555–562. doi:10.1001/archophthalmol.2009.3.
  • Yüksel T, Ramazan Y, Mesut E, Reyhan B, Ibrahim FH. Cyclosporin effectively inhibits posterior capsule opacification after phacoemulsification in rabbits: a preliminary study. Clin Experiment Ophthalmol. 2008;36(1):62–66. doi:10.1111/j.1442-9071.2007.01653.x.
  • Cheng P, Yi X, Jean XJ, Cui LJ, Li L, Qin L. Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits. Int J Ophthalmol. 2013;6(1):1–7. doi:10.3980/j.issn.2222-3959.2013.01.01.
  • Peizeng Y. Clinical uveitis. Beijing: People’s Medical Publishing House; 2004. pp. 61–63.
  • Kruger AJ, Schauersberger J, Abela C, Schild G, Amon M. Two year results: sharp versus rounded optic edges on silicone lens. J Cataract Refract Surg. 2000;26(4):566–570. doi:10.1016/S0886-3350(00)00323-0.
  • Awasthi N, Wang S, Wagner BJ. Downregulation of MMP-2 and -9 by proteasome inhibition: a possible mechanism to decrease LEC migration and prevent posterior capsular opacification. Invest Ophthalmol Vis Sci. 2008;49(5):1998–2003. doi:10.1167/iovs.07-0624.
  • Lovicu FJ, Shin EH, McAvoy JW. Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract. Exp Eye Res. 2016;142:92–101. doi:10.1016/j.exer.2015.02.004.
  • Heather LC, Curtis AB, Ping L, Donna FK, Carmen MHC. Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition. Mol Vis. 2007;13:677–691.
  • Cortina P, Gómez-Lechón MJ, Navea A, Menezo JL, Terencio MC, Diaz-Llopis M. Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferationin culture. Graefes Arch Clin Exp Ophthalmol. 1997;235(3):180–185. doi:10.1007/BF00941726.
  • Radeke HH, Kuster S, Kaever V, Resch K. Effects of cyclosporin and FK-506 on glomerular mesangial cells. Evidence for direct inhibition of thromboxane synthase by low cyclosporin concentrations. Eur J Clin Pharmacol. 1993;44(S1):S11–S16. doi:10.1007/BF01428385.
  • Heather LC, Kristen JG, Elizabeth AL, Elizabeth MC, Rachel BM, David AW, Anne GM. Cyclosporine A prevents ex vivo PCO formation through induction of autophagy-mediated cell death. Exp Eye Res. 2015;134:63–72. doi:10.1016/j.exer.2015.03.020.
  • Jie W, Fengying K, Jing S. The effect of cyclosporine A on lens epithelial cells. Chin Ophthal Res. 2002;5:19–22.
  • Hongling L, Lan W, Shaoying F, Yongsheng H, Ping L, Hao C, Jingjing L, Xing L, Xiaomei Z. Polylactide-glycoli acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes. Graefes Arch Clin Exp Ophthalmol. 2009;247(6):801–807. doi:10.1007/s00417-008-1007-0.
  • Zhang RP, Xie ZG. Research progress of drug prophylaxis for lens capsule opacification after cataract surgery. J Ophthalmol. 2020;2020:2181685. doi:10.1155/2020/2181685.
  • Hecht I, Karesvuo P, Achiron A, Elbaz U, Laine I, Tuuminen R. Anti-inflammatory medication after cataract surgery and posterior capsular opacification. Am J Ophthalmol. 2020;215:104–111. doi:10.1016/j.ajo.2020.02.007.
  • Xiang Y, Zou M, Zhang Y, Jin R, Nie Y. Drug-loaded and blue-ray filtered hydrogel as a potential intraocular lens for cataract treatment. Pharm Nanotechnol. 2020;8(4):302–312. doi:10.2174/2211738508666200313144112.
  • Jiang J, Mahbubul HS, Yan W, Melinda KD. Lens epithelial cells initiate an inflammatory response following cataract surgery. Invest Ophthalmol Vis Sci. 2018;59(12):4986–4997. doi:10.1167/iovs.18-25067.
  • Won YH, Sauder DN, McKenzie RC. Cyclosporin A inhibits keratinocyte cytokine gene expression. Br J Dermatol. 1994;130(3):312–319. doi:10.1111/j.1365-2133.1994.tb02926.x.
  • Sharpe RJ, Arndt KA, Bauer SI, Maione TE. Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes. Arch Dermatol. 1989;125(10):1359–1362.
  • Hatfield SM, Roehm NW. Cyclosporine and FK506 inhibition of murine mast cell cytokine production. J Pharmacol Exp Ther. 1992;260(2):680–688.
  • Raquel EM, Inês L, Paulo SG, Rafael CB, Ana MQ, Walter R. Topical corticosteroids with topical cyclosporine A versus topical corticosteroids alone for immunological corneal graft rejection. Eur J Ophthalmol. 2022;32(3):1469–1481. doi:10.1177/11206721211023320.
  • Kang Y, Xiu-Fen L, Xiu-Ying J, Shi-You Z. Efficacy of immunosuppressants in high rejection risk keratoplasty: a meta-analysis of comparative studies. Cornea. 2021;40(6):800–807. doi:10.1097/ICO.0000000000002709.
  • Alejandro G, Estíbaliz L, Gerard E, José M, José MH, Santiago MF, Luis R, Miguel CC. Spanish Society of Ocular Inflammation (SEIOC). Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: a systematic literature review. Semin Arthritis Rheum. 2020;50(6):1299–1306. doi:10.1016/j.semarthrit.2020.08.010.
  • Alaql MK, Akinfe AA, AlNour MK. Treatment of Vogt-Koyanagi-Harada disease. Cureus. 2020;12(7):e9125. doi:10.7759/cureus.9125.
  • Ijeoma FU, Jan B, Alessandra Z, Uche O, Andreas GS. Polymeric micelles for the enhanced deposition of hydrophobic drugs into ocular tissues, without plasma exposure. Pharmaceutics. 2021;13(5):744. doi:10.3390/pharmaceutics13050744.
  • BenEzra D, Maftzir G, Courten C, Timonen P. Ocular penetration of cyclosporin A. III: the human eye. Br J Ophthalmol. 1990;74(6):350–352. doi:10.1136/bjo.74.6.350.
  • Nussenblatt RB, Dinning WJ, Fujikawa LS, Chan CC, Palestine AG. Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch Ophthalmol. 1985;103(10):1559–1562. doi:10.1001/archopht.1985.01050100135035.
  • Sang BH, Joo HK, Hee KY, Jeong-Min H. Efficacy of polytetrafluoroethylene/polylactide-co-glycolide(PTFE/PLGA) laminate and PTFE/PLGA laminate containing slow-releasing thalidomide in delayed adjustable strabismus surgery in a rabbit model. Curr Eye Res. 2019;44(7):806–812. doi:10.1080/02713683.2019.1591461.
  • Yue S, Bolun Z, Ruowei S, Wenfang L, Qubo Z, Xun Z, Rongrong W, Chuanpin C. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv. 2021;28(1):1397–1418. doi:10.1080/10717544.2021.1938756.
  • Susmita A, Sanghyo P, Chaewon P, Moon JC, Jaehong K. Porous discoidal polymeric particles for effective drug delivery minimizing phagocytosis. Artif Cells Nanomed Biotechnol. 2021;49(1):390–396. doi:10.1080/21691401.2021.1909605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.